ICICI Lombard General Insurance Company Limited has scheduled an analyst and institutional investor conference for May 27, 2026, in Mumbai as part of the Ashika Institutional Equities Investor Conference. The disclosure was filed by Company Secretary Vikas Mehra on May 5, 2026, in compliance with Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has explicitly stated that no unpublished price sensitive information will be shared during the meeting, ensuring adherence to fair disclosure norms. The meeting is scheduled to be held in-person in Mumbai as part of the Ashika Institutional Equities Investor Conference.
ICICI Lombard General Insurance Company Limited has allotted 103,173 equity shares of ₹10 each under its employee stock option schemes on May 6, 2026. The allotment was approved by a Whole-time Director exercising authority delegated by the Board of Directors during its meeting held on July 18, 2023. The shares were distributed across two specific schemes: 75,627 shares under the ICICI Lombard Employees Stock Option Scheme - 2005 and 27,546 shares under the ICICI Lombard - Employees Stock Unit Scheme - 2023. The newly allotted shares will rank pari-passu with existing equity shares in all respects, carrying the same rights, privileges, and obligations as outstanding shares.
Motilal Oswal has issued a buy rating on ICICI Lombard with a target price of ₹2,230 in its research report dated May 05, 2026. According to the brokerage's analysis, the insurance company is witnessing a sharp recovery in growth momentum, with 2HFY26 GWP growth of ~16% compared to the industry average of ~11%. This outperformance is attributed to a revival in motor insurance, strong traction in health insurance following GST changes, and steady commercial lines performance. The company's stock has shown positive momentum with historical returns of +1.90% (1 day), +2.20% (5 days), +7.20% (1 month), +24.73% (6 months), and +11.24% (1 year).
The company's growth momentum is being supported by multiple factors across different insurance segments. As reported by Motilal Oswal, the sharp recovery in growth momentum is driven by a revival in motor insurance, strong traction in health insurance post GST changes, and steady commercial lines performance. The brokerage notes that ICICI Lombard is well-positioned to sustain mid-teen growth with strengthening demand across segments, indicating a positive outlook for the company's future performance.
The stock has experienced a correction in recent months and is currently trading at 22x FY28E P/E, according to Motilal Oswal's research. This current valuation is significantly lower than the five-year average of one year forward P/E of 35x. The brokerage has set the target price of ₹2,230 based on 28x FY28E EPS, suggesting the stock may be undervalued at current levels given its strong growth prospects and market position. The company's participation in the upcoming analyst conference may influence institutional shareholding patterns and provide insights into future growth strategies in the underpenetrated insurance segments.
